Healthpeak Properties (DOC) insider trading
Insider activity, historical context and SEC filings · data through Nov 20, 2026
No open-market insider buying in the last 12 months. Selling alone is common (taxes, diversification) and isn't treated as a signal here.
Label: Net selling · based on open-market trades (codes P and S), last 12 months. Not a rating or advice.- Next earnings expected around Feb 2, 2027 (estimate from past release dates). Insiders usually trade in the weeks after results; past reactions ↓
Sale Ankit B. Patadia, Evp And Treasurer sold 6,115 shares at $20.78 ($127K).
- Trade date
- Nov 9, 2026
- Disclosed to the SEC
- Nov 9, 2026
- Type
- Sale (code S)
Read the original SEC filing ↗All DOC insider trades ↓
Insiders have two business days to report a trade to the SEC, so filings (and our alerts) always come after the trade, never in real time.
DOC insider transactions (Form 4)
Open-market purchases and sales. 44 grants, option exercises and tax withholdings are not shown.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| Nov 9SEC | Ankit B. PatadiaEvp And Treasurer | Sell | 6,1152,838 held (−68%) | $20.78 | $127K | -7.8% | — |
| May 13SEC | Scott R. BohnCdo And Head Of Lab | Sell | 10,9897,636 held (−59%) | $19.45 | $214K | -1.5% | — |
Similar past setups: not applicable. DOC has had no open-market insider purchases in the last 12 months, so there's no buying setup to compare with history. When insiders buy, this section shows how 6,290 similar past buys did over 90 days. How we calculate this →
Play with DOC in the Research Lab
DOC has no open-market insider buys in the last 12 months. Try the tools with any setup.
Quick backtest: did buys like this beat the market?
Tap a setting to see how 6,290 past insider buys did.
Share price and insider trades
Healthpeak Properties insider trading at a glance (Nov 20, 2026): in the past 12 months, 0 insiders bought $0 and 2 sold $341K of DOC stock on the open market; P/E 66.0 vs. a sector median of 24.0.
By InsiderPrint Research Desk · Updated · Sources: SEC EDGAR Form 4 filings, FINRA short-sale volume · How we calculate this
DOC insider buying and selling by quarter
Open-market purchases (green, above the line) and sales (red, below), by trade date.
| Quarter | Bought | Purchases | Sold | Sales |
|---|---|---|---|---|
| Q4 2026 | — | 0 | $127K | 1 |
| Q3 2026 | — | 0 | — | 0 |
| Q2 2026 | — | 0 | $214K | 1 |
Valuation, profit and volume
Source: SEC filings, as of Nov 16, 2026. Volume and paper profit use daily closing prices.
Summary
Over the past 12 months, 0 Healthpeak Properties insiders reported open-market purchases totaling $0, while 2 insiders reported sales totaling $341K. 0 of 2 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.
DOC earnings: how the stock reacted
Each quarterly results release (SEC 8-K Item 2.02), the trend before it, insider trades in the 30 days before, and the 2-day market reaction. “E” marks releases on the chart above.
| Release | 15 days before | Insiders, 30 days before | Reaction (2 days) | Next 30 days |
|---|---|---|---|---|
| Nov 2, 2026 | +0.9% | None | +2.8%S&P -0.2% | pending |
| Aug 4, 2026 | -3.4% | None | +0.7%S&P +1.6% | -4.8% |
| May 5, 2026 | -6.2% | None | +19.7%S&P +2.2% | +2.0% |
| Feb 2, 2026 | -1.2% | None | -4.6%S&P -0.4% | +6.5% |
| Oct 23, 2025 | -2.2% | None | +0.8%S&P +1.4% | -4.3% |
| Jul 24, 2025 | +5.2% | None | -7.6%S&P +0.5% | +1.4% |
| Apr 24, 2025 | +5.2% | None | -5.3%S&P +2.8% | -5.0% |
| Feb 3, 2025 | -0.2% | None | -2.9%S&P -0.0% | +1.9% |
Most companies bar insiders from trading in the weeks before results, so pre-earnings purchases are rare and often made by directors or under pre-set plans. Past reactions don't predict future ones.
DOC short selling
Daily short-sale volume as a share of trading volume (FINRA), with the 20-day average.
This is short volume from off-exchange trades, not short interest. It includes market makers' routine hedging, so 40–50% is normal; what stands out is a ratio well above the stock's own average. Insiders buying while shorts pile in →
Members of Congress who traded DOC
From STOCK Act disclosures. Reported up to 45 days after the trade, in dollar ranges.
| Member | Trade | Traded | Reported | Since trade |
|---|---|---|---|---|
| Alan ArmstrongSenate | Bought $1,001 - $15,000 | Mar 27, 2026 | Jul 21, 2026 | +19.1% |
Insiders at Healthpeak Properties
| Insider | Bought | Sold | Last filing | Past buys beat S&P | Score |
|---|---|---|---|---|---|
| Scott R. BohnCdo And Head Of Lab | — | $214K | May 13, 2026 | — | — |
| Ankit B. PatadiaEvp And Treasurer | — | $127K | Nov 9, 2026 | — | — |
| John T. ThomasDirector | — | — | Nov 13, 2026 | — | — |
| Sara Grootwassink LewisDirector | — | — | Nov 5, 2026 | 2 of 3 | — |
| Shawn G. JohnstonEvp And Cao | — | — | Jun 2, 2026 | — | — |
| Scott M. BrinkerCEO, President | — | — | Jun 2, 2026 | — | — |
| Kelvin O. MosesCFO | — | — | Jun 2, 2026 | — | — |
| Adam G. MabryCio | — | — | Jun 2, 2026 | — | — |
| R. Kent Griffin Jr.Director | — | — | May 7, 2026 | — | — |
| James B. ConnorDirector | — | — | May 7, 2026 | — | — |
| Richard A. WeissDirector | — | — | May 7, 2026 | — | — |
| Brian G. CartwrightDirector | — | — | May 7, 2026 | — | — |
| Katherine M. SandstromDirector | — | — | May 7, 2026 | — | — |
| Ava Lias-BookerDirector | — | — | May 7, 2026 | — | — |
| Lisa A. AlonsoEvp And Chief Hr Officer | — | — | Feb 17, 2026 | — | — |
Board links: companies that share insiders with DOC
Directors and executives who filed Form 4s for DOC and another company in the last 12 months.
- JANJanus Living Katherine M. Sandstrom Director here · Director at JAN · latest filing May 7, 2026Scott M. Brinker CEO, President here · CEO, President at JAN · latest filing Jun 2, 2026
- FCXFreeport-McMoRan Sara Grootwassink Lewis Director here · Director at FCX · latest filing Nov 5, 2026
- PLDPrologis James B. Connor Director here · Director at PLD · latest filing May 7, 2026
- TOLToll Brothers Katherine M. Sandstrom Director here · Director at TOL · latest filing May 7, 2026
- WYWeyerhaeuser Sara Grootwassink Lewis Director here · Director at WY · latest filing Nov 5, 2026
Insider activity at other Real Estate companies
Same sector, ranked by insider buying in the last 90 days.
DOC stock: common questions
Are Healthpeak Properties insiders buying DOC stock?
No. No Healthpeak Properties insider reported an open-market purchase of DOC in the past 12 months.
Are Healthpeak Properties insiders selling DOC stock?
2 insiders reported sales worth $341K over the same period.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.
What is DOC's P/E ratio?
DOC trades at about 66.0 times trailing earnings, compared with a median of 24.0 for the Real Estate sector.
What is DOC's 52-week range?
Over the past year DOC has traded between $15.03 and $22.59. It last closed at $19.16 on Nov 19, 2026.